Lymphopenia and fumaric acid esters for psoriasis: a retrospective case series prompted by the European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) recommendations.
作者信息
Roche L, Lynch M, Ahmad K, Hackett C, Ramsay B
机构信息
Department of Dermatology, University Hospital Limerick, Dooradoyle, Limerick, Ireland.
出版信息
Clin Exp Dermatol. 2018 Jan;43(1):72-75. doi: 10.1111/ced.13277. Epub 2017 Oct 13.
PMID:29027699
Abstract
摘要
相似文献
1
Lymphopenia and fumaric acid esters for psoriasis: a retrospective case series prompted by the European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) recommendations.淋巴细胞减少症与富马酸酯治疗银屑病：一项由欧洲药品管理局药物警戒风险评估委员会（PRAC）建议引发的回顾性病例系列研究。
Clin Exp Dermatol. 2018 Jan;43(1):72-75. doi: 10.1111/ced.13277. Epub 2017 Oct 13.
2
Lymphopenia and CD4+/CD8+ Cell Reduction under Fumaric Acid Esters.富马酸酯类药物导致的淋巴细胞减少和 CD4+/CD8+细胞减少。
Dermatology. 2017;233(4):295-302. doi: 10.1159/000478903. Epub 2017 Sep 28.
3
Fumaric acid ester-induced T-cell lymphopenia in the real-life treatment of psoriasis.富马酸酯诱导的 T 细胞淋巴细胞减少症在银屑病的真实生活治疗中。
J Eur Acad Dermatol Venereol. 2019 May;33(5):893-905. doi: 10.1111/jdv.15448. Epub 2019 Feb 28.
4
The Implications of Recent Recommendations for Managing Patients with Psoriasis Treated with Fumaric Acid Esters.最近推荐的治疗用富马酸酯治疗银屑病患者的建议的影响。
Dermatology. 2017;233(2-3):175-177. doi: 10.1159/000479792. Epub 2017 Sep 5.
5
A case series of persistent lymphopaenia following treatment with fumaric acid esters for psoriasis.银屑治疗后持续性淋巴细胞减少症的病例系列。
J Clin Pharm Ther. 2021 Jun;46(3):859-861. doi: 10.1111/jcpt.13354. Epub 2021 Jan 11.
6
Fumaric acid esters as a suitable first-line treatment for severe psoriasis: an Irish experience.富马酸酯作为重度银屑病的合适一线治疗方法：爱尔兰的经验
Clin Exp Dermatol. 2012 Oct;37(7):793-5. doi: 10.1111/j.1365-2230.2012.04351.x. Epub 2012 Apr 30.
7
Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases.用于重度银屑病的富马酸酯：58例回顾性研究
Br J Dermatol. 2005 Sep;153(3):549-51. doi: 10.1111/j.1365-2133.2005.06728.x.
8
Fumaric acid esters in the management of severe psoriasis.富马酸酯类药物在重度银屑病治疗中的应用
Clin Exp Dermatol. 2007 May;32(3):246-9. doi: 10.1111/j.1365-2230.2007.02389.x. Epub 2007 Mar 14.
9
Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis.重度银屑病中富马酸酯全身治疗的长期安全性问题
Br J Dermatol. 2003 Aug;149(2):363-9. doi: 10.1046/j.1365-2133.2003.05433.x.
10
Fumaric acid therapy in psoriasis: a double-blind comparison between fumaric acid compound therapy and monotherapy with dimethylfumaric acid ester.
Dermatologica. 1990;181(1):33-7. doi: 10.1159/000247856.
引用本文的文献
1
Fumaric acid ester-induced T-cell lymphopenia in the real-life treatment of psoriasis.富马酸酯诱导的 T 细胞淋巴细胞减少症在银屑病的真实生活治疗中。
J Eur Acad Dermatol Venereol. 2019 May;33(5):893-905. doi: 10.1111/jdv.15448. Epub 2019 Feb 28.
2
Long-term real-life safety profile and effectiveness of fumaric acid esters in psoriasis patients: a single-centre, retrospective, observational study.在银屑病患者中，富马酸酯类药物的长期真实世界安全性和有效性：一项单中心、回顾性、观察性研究。
J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1710-1727. doi: 10.1111/jdv.15019. Epub 2018 May 18.
Zotero 插件